Tricida nets from the offering approximately $193M
Tricida estimates that the net proceeds from the offering will be approximately $193.0 million
Pharmaceuticals, Biotechnology and Life Sciences
Tricida estimates that the net proceeds from the offering will be approximately $193.0 million
Takeda’s Alunbrig long-Term results from the phase 3 ALTA 1L trial established Alunbrig as a superior first-line treatment compared to crizotinib for people with ALK+ metastatic NSCLC, including those with brain metastases.
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) announced today that, due to public health and safety concerns related…
Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.
AstraZeneca has concluded the first agreements for at least 400 million doses and has secured total manufacturing capacity for one billion doses so far and will begin first deliveries in September 2020.
$1.88 million in biomedical research grant funding for 2020 Class DENVER–(BUSINESS WIRE)–#cobioscience–The Boettcher Foundation has selected eight researchers to receive…
DUBLIN–(BUSINESS WIRE)–The “Biologics Global Market Report 2020-30: COVID-19 Impact and Recovery” report has been added to ResearchAndMarkets.com’s offering. This report…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Packaging – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The Pharmaceutical Packaging…
DUBLIN–(BUSINESS WIRE)–The “Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)”…
MISSISSAUGA, Ontario–(BUSINESS WIRE)–MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of healthcare industry executive Damon Goodwin…